http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-4950520-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D223-22 |
| filingDate | 1998-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_828c25a4cf6c553aec77799205b937d9 |
| publicationDate | 2000-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CO-4950520-A1 |
| titleOfInvention | PARENTERAL FORMULATIONS OF 5H-DIBENZ (B, F) AZEPIN-5- CARBOXIAMIDES USEFUL IN THE TREATMENT OF EPILEPTIC ATTACKS |
| abstract | The present invention relates to a parenteral formulation comprising a 5H-dibenz (b, f) azepin-5-carboxamide and water or a water-based solvent, wherein the formulation does not contain other solubilization aids. A parenteral formulation comprising a 5H-dibenz (b, f) azepin-5-carboxamide, water or a water-based solvent, and glucose. A parenteral formulation comprising 10-hydroxy-10,11-tetrahydrocarbamazepine and water. A parenteral formulation according to claim 3, which further comprises an isotonic agent. A parenteral formulation according to claim 3 or claim 4, wherein the isotonic agent is glucose. A parenteral formulation according to claim 2 and 5, wherein glucose is present in an amount of 4.75 weight percent, based on the total weight of the parenteral formulation. A unit dosage form comprising an effective amount of a 5H-dibenz (b, f) azepin-5-carboxamide and water, or a water-based solvent, wherein the unit dosage form does not contain other solubilization aids. |
| priorityDate | 1997-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.